- 11159 pg/mL
Control II HADK2-211 24089 - 50031 pg/mL
IL-8 Control I HADK2-111 70 - 146 pg/mL
Control II HADK2-211 305 - 633 pg/mL
MCP-1 Control I HADK2-111 148
should be used within
24 hours of reconstitution.
References
1. Larios, B., et al., Planta, 212(2), 305-12 (2001).
2. Schomburg, D., et al., Enzyme Handbook 7,
Springer-Verlag (Berlin: 1994).
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931 NA NA M y y y
216 Anti Cy3+Cy5 C0992 NA NA M
225 Dnase I D0188 NA
clone AB6 H M WB IP IC M IgG1κ 100 µg 05-212 $339
Anti-PI 3-Kinase, p85, N-SH2, clone UB93-3 H M R WB IP M IgG 200 µL 05-217 $329
Anti-PI 3-Kinase p85α, clone 8-2D-4D H
y n/d y
210 Cytokeratin peptide 18 C1399 M y n/d n/d
211 Cytokeratin peptide 19 C6930 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 M y n/d
100 µg 05-212
Anti-PI3 Kinase, p85, N-SH2 UB93-3 H M R IP WB Sup M IgG 200 µL 05-217
Anti-PI3 Kinase, p85a, Rb Mab H M R FC IP WB Rb IgG 100 µL 04-403
IC IH(P)
KRT18 NP_954657.1 M y n/d n/d
211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y
KRT18 NP_954657.1 M y n/d n/d
211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y